Herantis Pharma`s Manager`s Transactions
Herantis Pharma Plc
Company release 2 Jan 2017 at 9:00 am
Herantis Pharma Oyj - Managers` Transactions
____________________________________________
Person subject to the notification requirement
Name: Meles Consulting Oy, Controlled company of Pekka Simula
Position: Chief Executive Officer
(X) Legal person
Issuer: Herantis Pharma Oyj
LEI: 743700W4CQVYAT3WKK38
Notification type: INITIAL NOTIFICATION
Reference number: 743700W4CQVYAT3WKK38_20161230145023_1
____________________________________________
Transaction date: 2016-12-30
Venue: FIRST NORTH FINLAND (FNFI)
Instrument type: SHARE
ISIN: FI4000087861
Nature of the transaction: ACQUISITION
Transaction Details
(1): Volume: 1000 Unit price: 3,00000 EUR
Aggregated transactions
(1): Volume: 1000 Volume weighted average price: 3.00000 EUR
Further information:
Herantis Pharma Plc, Pekka Simula, CEO, telephone: +358 40 7300 445
Company web site: www.herantis.com
Certified Advisor: UB Securities Ltd, telephone: +358 9 25 380 246
Distribution:
Nasdaq Helsinki
Main media
www.herantis.com
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Herantis Pharma Oyj via GlobeNewswire
HUG#2068234